Abstract
Pleural infections can be associated with significant morbidity and mortality. Systemicantibiotics and drainage are the standard treatment, but some patients require surgicalintervention for complete resolution. For unsuitable surgical candidates, the intra-pleuraladministration of tissue plasminogen activator and deoxyribonuclease (tPA/DNase) is apotential treatment option for loculated effusions. We present a case of loculated empyemasuccessfully treated with a 3-day course of once daily intra-pleural administration of tPA/DNase. Considering the frailty of our patient, we choose the once daily tPA/DNase due toconcerns about potential complications, such as increased risk of bleeding. The published trialevidence and administration regimens of intra-pleural tPA/DNase are also discussed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Southwest Respiratory and Critical Care Chronicles
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
